Research programme: metabolic disorders therapy - AdipoGenix/ChemDiv
Latest Information Update: 27 Mar 2009
At a glance
- Originator AdipoGenix; ChemDiv
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus
Most Recent Events
- 27 Mar 2009 Discontinued - Preclinical for Obesity in USA (unspecified route)
- 27 Mar 2009 Discontinued - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)
- 26 Jul 2005 Preclinical trials in Obesity in USA (unspecified route)